The research-grade ADOS is a broadly used instrument that informs and steers 12 much of the science of Autism. Despite its broad use, little is known about the empirical 13 variability inherently present in the scores of the ADOS scale, or their appropriateness to 14 define change, to repeatedly use this test to characterize neurodevelopmental trajectories.
We may also need to begin to think about new mathematically appropriate ways to track 158 neurodevelopment while using behaviorally based observational means. For example, in 159 pediatrics, the Growth Charts from the CDC and the WHO serve the purpose of establishing 160 normative criteria to measure departure from typical development, as the child physically 161 grows. In Autism, there is nothing comparable to the growth charts, so there are no metrics 162 of similarity to detect and track change and its rate. It has now been established that 163 observational behavioral criteria grounded on psychological (subjective) constructs drive the 164 scientific quest in Autism and supersedes physiological (objective) criteria [14; 19] , so the 165 time is ripe to build a similarity metric based on physiological data registered from the fast 166 growing and rapid developing nervous systems. 167 One fundamental difference between observation-driven clinical diagnostics tools 168 enforced in Autism research, and the physiological data that we have gathered across labs to 169 address basic scientific research in Autism (e.g. to characterize genetics, brain activity and 170 somatic-sensory-motor issues across different imaging and wearable sensors platforms, e.g. 171 [5; 6; 30; 31; 32; 33; 34] ) is that there is always a group of neurotypical controls included in 172 the study. This is so, to help us establish normative data and to ascertain departure from it 173 across the human lifespan. In contrast to the Autism research involving physiology and more 174 generally neurobiology, we could not find any study characterizing the neurotypical 175 population using the research-grade ADOS defining criteria for Autism (i.e. based on social 176 interactions and communication, and ritualistic repetitive behaviors, RRBs.) This is so 177 because the clinical version of the ADOS is not a norm-referenced test, but rather a criterion-178 referenced one. 179 As such, the research-grade ADOS which was adopted in science from the clinical 180 counterpart, has no proper metric to measure relative changes away from typical levels. In 181 this sense, although the ADOS modules were designed to account for possible disparities in 182 cognitive/verbal capacity, there is no age-dependent criteria in the research-adopted version 183 to ascertain physical rate of change and to measure departure from typical physiologic 184 maturation, i.e. maturation with respect to normative trends ( Figure 1A) . Even the so-called 185 "standardized" ADOS severity scores do not address this point, because as they were 186 developed for criteria-referenced for clinical use, the scale was not built using typical controls 187 as a norm-referenced test would be [35; 36; 37] . The score is designed to compare an 188 individual with ASD to other individuals with ASD of the same age and language level. It 189 also has a range of 6-10 for individuals with ASD and is not meant to represent ASD on a 190 range of 1-10. Autism is not only highly heterogeneous. It also has neurodevelopmental 191 asynchronies in a group of the same age, meaning that two individuals may be 10 years old, 192 but one may have the signatures of neuromotor control from normative 3-year-old children 193 [6] ( Figure 1A, B, D) . Thus, aging with autism is different than typically aging. 194 The absence of a similarity metric for the adopted research ADOS poses a challenge to 195 the scientific community. What is the normative range of scores that reflect age-appropriate 196 typical social interactions? 197 Because of the prevalent influence that the research-grade ADOS test has on basic 198 science at all levels, it is imperative to examine the inherent theoretical assumptions that 199 adopters of this test have made and verify that the outcome of this test -as administered in 200 research settings-empirically matches the theoretical assumptions of the users. 201 In the first part of this paper, we use the Autism Brain Imaging Data Exchange (ABIDE) 202 repository [38] to examine 1,324 clinical records of participants with ASD, with the purpose 203 of better understanding the inherent statistics of the ADOS scores obtained in research 204 settings. Specifically, we ask if the current theoretical statistical assumptions that the adopters 205 of the research-grade ADOS inventory make are in correspondence with the empirical cross-206 sectional (publicly available) data from the Autistic population across the human lifespan (5-207 65 years of age) ( Figure 3 ). In the second part of the paper, we examine the ADOS-2 scores' 208 6 of 28 distributions in 52 participants, 26 typical controls with no health or mental issues, and 26 209 participants suspected to have (and confirmed to have) Autism. We ask if the neurotypical 210 participants cluster at values significantly away from the 0-value denoting the absence of a 211 behavior that would be otherwise present; or if they significantly depart from 0. In the last 212 part of the paper, we longitudinally track a subset of the individuals with Autism who 213 returned to the lab 4 visits. We tested these participants using the same module (twice), each 214 module administered by different clinicians, to assess the extent to which such changes 215 impacted the scores that they received, despite adjusting for physical age. We report our 216 findings and encourage new transformative changes towards objective behavioral 217 characterizations to help advance Autism science toward the use of similarity metrics that 218 appropriately measure change and its rate along properly quantified neurodevelopmental 219 trajectories. 220
Methods

221
The Rutgers University Institutional Review Board (IRB) committee approved all 222 protocols used in this study. Parental and /or legal guardian consent was obtained for all 223 participants. All procedures were performed in compliance with the Helsinki Act under IRB 224 approval. For the consent process, we read and explained to the parents the IRB-approved 225 protocol and the child assent form. After the informed consent process, all 26 families 226 agreed to participate and signed written parent permission and assent forms. The common.) Each module is designed to provide the most appropriate test for an individual 236 at a certain language level. There is a newly created calibrated severity score (CSS) in 237 ADOS-2. It is based on the person's age as it converts an individual's Total ADOS-2 score 238 in comparison to other individuals with ASD at the same age and language level (for each 239 individual module). For the actual ADOS-2 administration age does not determine the 240 module but may determine algorithm items within that module. We note however, that two 241 children of the same age will very likely have very different neuromotor control age, as 242 assessed by objective physiological metrics. In general, age has no real meaning in 243 neurodevelopmental disorders, where the coping nervous systems of different individuals 244 born at similar dates, evolve at very different rates [6; 39] and see Figure 1 . Psychologist. Further, two clinically certified raters independently video-taped and 248 discussed the sessions to ensure module administration fidelity.
249
The two raters who administered the ADOS to the participants were research reliable. certified personnel in the study (4 total) made sure that the conditions were identical in 278 each session, task, child, rater and module.
279
Module Four -It is designed for individuals who are verbally fluent but no longer at 280 an age to play with toys. This module incorporates some Module Three elements, yet it is 281 more conversational regarding daily living experiences.
282
Often the examiner may choose one module and realize that the participant's 283 functional abilities anticipated by that module do not match the rater's expectation. Then 284 the tester may choose another module. This is a common practice. As such, the present 285 experiment manipulated the module type, to probe the participant's responses to the same 286 module administered by two different raters, or to determine the adequacy of the modules.
287
The modules involving playing with toys or objects have the tester present owing to the test's assumption that no significant sensory and motor issues are present. As 298 such, it is never possible to assess causality. For all these reasons, and because our lab The response of the child determines the score. Likewise, the way in which the rater 307 evokes the response influences the child's choice of actions that are consequential to the 308 rater's provoking actions. To probe the extent to which a change in the tester influenced 309 the scoring, our experiment manipulated the rater as a parameter, while holding all other 310 conditions constant in two different visits. Participants came to the lab a total of four visits.
311
For each participant, two modules were selected, and research-reliable testers were 312 employed. One module was rendered the most adequate one, while the other was rendered 313 the feasible one. By most adequate, we mean that the module was at the child's verbal 314 level and developmental level, while feasible means that the child could perform the entire 315 module, but it would not be the adequate one to perform a diagnosis or to aid a clinician 316 in performing a diagnosis of autism. We note that previous research indicates that 317 inappropriate ADOS module use invalidates the assessment and the scores do not 318 accurately reflect the child's performance on the assessment. Nevertheless, since this study 319 is not about diagnosing autism, but rather it is about evaluating the use of this ADOS test 320 in basic science, specifically assessing the variability that using different raters may add 321 to the scores; in addition to changing the rater, we are also manipulating the use of the 322 modules across different visits.
323
Each module took between 40-60 minutes to complete. Both the rater and the 324 participant were recorded by two video cameras from different angles and by wearable 325 smart sensors that they wore embedded in the clothing, as wrist watches on the wrists and 326 on the ankles. The digital data will be the subject of a different paper. Additional 327 information about the ADOS test can be found in the Supplementary Table. 328 329
Open Access Data: The ABIDE records contain ADOS-2 and ADOS-G scores that we 330 extracted to plot the distributions of these tests sub-scores across 1,324 participants, ranging 331 between 5-65 years of age. We present the distribution of participants in Figure 3 
337
Clinical tools for diagnoses use the tenets of Signal Detection Theory, SDT [44; 45] , 338 albeit in a black-box approach that has never verified the implicit assumptions made by the 339 statistical packages that such papers report. Non-parametric methods to correct for non-340 normality are inadequate in a diagnostics test [23] . For example, in the ADOS, as in many 341 other clinical tests, the clinician plays the dual role of being the stimulus (via the prompts to 342 evoke social overtures and/or primed responses) and at the same time, being the observer, 343 scoring the participant's response. As such, the outcome of this test, which is presumed to 344 measure social interactions between two people, heavily depends on the clinician. In the 345 absence of the required assumptions of normality and variance homogeneity, the sensitivity Because of the broad use of this test in Autism research, and the possibility that the 349 assumptions required for research validity may not be met, it becomes crucial to verify the 350 normality assumption along with the assumption that the rater's bias and response are 351 independent. To that end, we take the unique opportunity that ABIDE offers with thousands All studies in the ABIDE data repository were performed under IRB approval in accordance 371 with the Helsinki Act. In-person Data Collected at the Lab: In the second part of the study, we measure the 379 outcome of the ADOS-2 test in 52 individuals, 26 controls (ages 7-66 years old) and 26 380 suspected to have (and then diagnosed with) Autism spectrum disorders (4-20 years old). We 381 used the baseline visit 1 to characterize the participants diagnosed with ASD and those who 382 were neurotypical. This was done to ascertain the extent to which the scores' range from 383 typical control participants deviate from the 0-scores denoting the absence of behavior 384 otherwise present and contributing to the overall cut-off number. We were motivated by the 385 critical need to create a similarity metric for Autism research. Given the adoption of the 386 research-grade ADOS for research and the fact that this observational inventory is not a 387 norm-reference test [1], we ascertained the spread of scores obtained from neurotypicals 388 away from 0. We quote from the ADOS-G paper: "Replication of psychometric data with 389 additional samples including more homogeneous non-Autistic populations and more 390 10 of 28 individuals with pervasive developmental disorders who do not meet Autism criteria, 391 establishing concurrent validity with other instruments, evaluation of whether treatment 392 effects can be measured adequately, and determining its usefulness for clinicians are all 393 pieces of information that will add to our understanding of its most appropriate use." 394 (emphasis added). Table 1 shows the 52 participants' scores and ages at baseline visit where 395 the most appropriate ADOS-2 module was selected for each child.
396
In 14 of the individuals with ASD (mean 9.3 years old ± 3.0), we re-assessed them across 397 4 visits taking place within 1.3 years on average (± 6 months), to ask the extent to which 398 switching the clinician and / or the ADOS-module would change the outcome of the test for 399 the same child. To that end, for each child, in the first two visits, we used the same clinician 400 but used two different ADOS-modules. According to each assessment in each visit, the raters 401 determined the modules that were the most appropriate and feasible. From these assessments 402 the 14 individuals described are those for which the second round of visits (visit 3 and 4) 403 retained the same appropriate and feasible modules despite the passage of time.
404
The first module (visit one) determined the most appropriate module at baseline, for the 405 given child. The second module (visit 2) was feasible (the child could do it) but was not 406 appropriate. For example, if the most appropriate module in visit 1 was module 3, we would 407 choose module 2 for visit 2. Then the same clinician would give these two modules whenever 408 the participant retrained the set of modules from visits 1 and 2, according to the raters' 409 evaluation; and the same two modules were then administered in subsequent visits (by a 410 different rater); module 3 in visit 3 and module 2 in visit 4 (see Table 2 .) 411 We switched clinician and maintained module fidelity and identical room set up. In this 412 way, each child had a chance to become familiar with the 2 modules by the time that we 413 switched the clinician. Those two same modules in the same order as the first two visits, 414 would then be administered by the new clinician to give us a chance to probe the influences 415 of the clinician on the child's response. The flexibility in task administration according to the 416 child's responses was respected to ensure fluid responses. 417 We hypothesized that this switching of clinicians (despite the use of the same modules' 418 and tasks' order in each administration), would have a substantial effect on the ADOS sub-419 scores, thus significantly impacting the reliability of the total score and the cut-off for the 420 diagnosis given to the child by the rater (clinician). To test this hypothesis, we used non-421 parametric statistics whereby we do not assume any distribution a priori. Table 2 shows the 422 14 scores across the 4 visits. Module 2 is very sparsely used). Figure 5 shows the corresponding frequency histograms for 461 ADOS-G. The empirical cumulative distribution functions (CDFs) for each criterion are 462 shown in Figure 4D for ADOS-2 and Figure 5D for ADOS-G. They were tested separately 463 as they are different ADOS versions, as were each sub-score distribution. Notice here the 464 similarities across CDFs for Module 3 and Module 4 and the similarity of each of these 465 empirically estimated CDFs with the CDF corresponding to all scores. We note that pooling 466 all scores is not valid, yet we do it here to show that the shape and dispersion of these 467 histograms are quite similar despite the differences in Module's tasks.
468
The Lilliefors test failed the normality test with p << 0.01 for each sub-score of each 469 ADOS test version. We also used maximum likelihood estimation (MLE) and fit several 470 distributions to assess the best fit with 95% confidence. The MLE revealed the continuous 
ADOS scores Cannot distinguish between Females and Males 485
The ADOS score data from ABIBE were divided into the male and female participants 486 to ascertain (1) if the distributions of the total and sub-scores were symmetric (test for Despite the well-established physiological and neurobiological distinctions between 510 males and females in the spectrum of Autism, here we could not find any statistically 511 significant difference between the ADOS-G (or the ADOS-2) total scores to automatically 512 separate these two distinct phenotypes. We could not find either statistically significant 513 differences between the sub-scores of each ADOS test, when comparing males and females 514 using the Wilcoxon ranksum test, as all p-values were above 0.5.
515
However, we did notice a significant difference in the distributions of the total scores for 516 males when comparing those of the ADOS-G vs. those of the ADOS-2, (center panel in 517 Figure 6B ). This difference was assessed using the Kolmogorov-Smirnov test for 2 empirical 518 distributions and yielded p-value of 0.0015. In contrast, this statistically significant difference 519 was absent in the ADOS-G vs. ADOS-2 comparison of total scores from the females' data 520 with a p-value of 0.8 ( Figure 7A center) . Note here that these comparisons do not have 521 meaningful clinical value. They are exclusively taken within a research framework to learn 522 whether two versions of the same test always yield consistent separation; or to learn if in 523 some cases they do not.
524
Given the visible separation of ADOS-G and ADOS-2 scores for the males, we 525 proceeded to further interrogate the cohort of participants with AS according to the DSM-IV 526 classification. This is possible as ABIDE provides the information on DSM-IV vs. DSM-5 527 on two separate columns of the data matrix. We then asked if the males with AS were also 528 14 of 28 separable from the males with ASD, according to the ADOS scores from the two versions of 529 the same test. Notice here the relevance of this question, as the ADOS-G and ADOS-2 are 530 indistinctly used in Autism research (as instantiated by the ABIDE repository), and no 531 differentiation is ever made by peer-reviewed papers that use one or the other to inform and 532 guide the results from their physiology/neurobiology-based research. We expected that despite their subtle differences, the variants of the same test would 536 provide consistent results for participants with AS and for those with ASD. In the case of 537 ADOS-G, we found a statistically significant difference between the scores of males with 538 ASD and those with AS, using the Wilcoxon ranksum test yielding a p-value of 3.7x10 -7 .
539
Further, the Kolmogorov-Smirnov test comparing 2 empirical distributions yielded a p-value 540 of 2.4x10 -6 , thus rendering the two distributions for AS and ASD statistically different at the 541 0.05 level (i.e. rejecting the null hypothesis that the two sets came from a similar distribution.)
542
In contrast to the ADOS-G, the ADOS-2 total score comparison (i.e. within the same 543 test) between the males with ASD and AS, using the Wilcoxon ranksum test, yielded a p-544 value of 0.31, non-significant at the 0.05 level. The Kolmogorov-Smirnov test comparing 2 545 empirical distributions yielded a p-value of 0.5, with no significant difference and failing to 546 reject the null hypothesis that the two data sets came from a similar distribution. Figure 6 547 shows the frequency histograms and CDF fits to the empirical data for males using the left- Asperger's syndrome. 571 We note that given the differences in sample size and the non-normality in the 572 distributions of scores, in all above comparisons, we used the Wilcoxon rank sum test. This The analyses of the in-person visit to assess the ADOS-2 in 52 participants, 26 suspected 579 (and confirmed) to have Autism or ASD and 26 typical controls, yielded significantly 580 different distributions of scores between the two age-and sex-matched groups. Figure 8A 
711
The nervous system of an individual with autism is a coping system with self-correcting 712 mechanisms that evolve over time and give rise to non-uniform developmental trajectories 713 [39] . This means that a transformation-operation that e.g. considers age, to change non-714 normal distributions into normal distributions (i.e. to call it a standard measure as in the 715 standardized severity score) will not address the fundamental problem of the individual that 716 is developing with a coping nervous system. The problem that we bring for consideration to 717 the scientific community doing research on autism is not one of the statistical 718 (in)appropriateness of a test, but rather of the need for tests that reflect the self-correcting 719 nature of nervous systems. Instead of masking the phenomena of relevance with some 720 transformation of the data to make up for normality, or altogether enforcing normality, we 721 need to use a data-driven approach.
722
Data-driven approaches tend to preserve empirically assessed features of phenomena.
723
They do not throw away important variability and as such, offer the possibility of capturing 724 the true nature of change in a coping neurobiological system that is developing at atypical 725 rates. Although this paper uses the ADOS test as the example to illustrate the potential 726 problems that blindly adopting such tests for scientific research may create, the same tenets 727 apply to any other clinical test used in basic research of neurodevelopmental disorders. These 728 disorders reflect in great part problems with the nervous systems and since nervous systems 729 20 of 28 are adaptable, we would be missing self-correcting mechanisms by imposing theoretical 730 models without empirically informing those models.
731
In the context of this test, changes in the distributions' shape and dispersion (across ages 732 and sex) imply lack of independence between sensitivity and bias. As such, the rater's 733 inherent bias and the non-normality of scores' probability distributions cast doubt on the 734 appropriateness of signal detection theory (SDT) and the Receiver Operating Characteristic 735 ROC-area-under-the-curve as criteria testing the sensitivity and reliability of this test.
736
There remains an absolute lack of a proper standard range of scores with physiological 737 interpretation, despite claims that the ADOS has been standardized [35; 36; 43; 53; 54; 55] .
738
Given these findings, it may be important to reconsider adopting this test to inform basic 739 scientific research in neurodevelopment. Across a multitude of research papers, discrete 740 scores that do not have a proper metric are systematically forced to be (linearly) correlated 741 with continuous physical data, yet the lack of normality in the distributions of the scores 742 along with the lack of independence between raters' bias and sensitivity pose a problem for 743 its validity in research, according to SDT and ROC area-under-the-curve types of analyses 744 [56] . One now wonders how many false positives we may have in research studies. What 745 does it really mean to have Autism, or to be on the Autism spectrum? And how can that 746 distinction be made relative to normative data from typically developing controls, when no 747 such data exist? Here we see, even in a rather modest cohort of neurotypical participants, that 748 there is not such a thing as a 0-score (or even epsilon-value score) for typical As stated, neurodevelopment occurs at highly non-linear accelerated rates. In a coping 753 nervous system, age is a non-uniform quantity in that any two given children with the same does not produce an official diagnosis, its use in research labs in the US, could serve as a flag 781 to send parents to federally certified clinics that offer services upon multi-prone criteria 782 involving other tests. However, owing to copyright issues, the Western Psychological 783 Services Firm, WPS company does not allow researchers copy, reproduce or share the ADOS 784 booklet with important details of the outcome. In other words, those children that come to 785 our labs and receive the research-grade ADOS and pass the cut-off scores are labeled autistic 786 by this test. However, as researchers, we are not allowed to share details with their parents.
787
This obstructs their ability to go to a proper clinic and pursue the diagnosis that will give 788 them access to Early Intervention Programs or to Individualized Education Programs in cases 789 when the child is of school age. If the WPS and the trainers of the ADOS allowed this, the 790 test adopted by researchers would serve as a warning to parents that some aspects of the 791 child's neurodevelopment may be off track.
792
Unlike the statistical confounds that the ADOS total scores and sub-scores surely bring 793 to research, in its current form at the clinic, the ADOS provides psychological comfort to 794 adults who had never been previously diagnosed and could not understand their place in the 795 social scene. Many adults, newly diagnosed at the clinic, express a sense of relief upon 796 learning that they are on the Autism spectrum and as such have social-interaction differences.
797
Further, the ADOS adds important information to the coarser DSM diagnosis. Thus, the 798 clinical value of this instrument is highly appreciated. However, its use as a research 799 instrument to inform physiological studies, is clearly now questionable and should be 800 discussed among the scientific community, particularly the community with the skill set to 801 fully understand statistics beyond black-box approaches that utilize software packages, i.e. 802 without ever verifying the assumptions of the methods implemented by those packages. 803 We should point out that the SDT framework used by the ADOS to test validity, was 804 introduced to science in the late 50's to address very different problems in engineering. It 805 was adapted to Psychophysics in Psychology under very different conditions than the types 806 of social interactions presumably tested by the ADOS would require. Here we have a test of 807 social interactions, i.e. a physical dance that takes place as a dialogue between two human 808 beings. Yet, this test is treated as a monologue. In this monologue, the same person that sends 809 the message, receives it and scores it, thus acting simultaneously as the stimulus and the 810 response, plus some 'noise' produced by the variability in the responses by the individual 811 being observed, assessed and rated. Although the test provides a protocol for structured social 812 exchange, in its present form, this test cannot tell us much about the types of somatic-sensory-813 motor issues that are by now well-established in Autism by the scientific community [4; 6; 814 27; 58; 59; 60; 61; 62; 63; 64; 65; 66; 67; 68; 69; 70; 71] and recognized by the inclusion of 815 sensory criteria in the DSM-5. For example, the most problematic sub-score in this example, 816 the RRB, is inherently a sensory-motor component difficult to predict, owing this to its 817 somewhat random appearances. Much like predicting a seizure or anticipating a self-injurious 818 episode, RRBs spontaneously emerge in inexplicable forms, sometimes seemingly 819 independent of the rater's abilities or training, sometimes seemingly triggered by the 820 uncertainty that the ADOS questioning brings to the person under examination. To predict 821 them with high certainty, we would have to first characterize them with instruments that 822 pickup information that escapes the naked eye. opportunity to uncover the inherent capabilities and predispositions that a coping nervous 831 system develops [39] .
832
The ADOS test nevertheless still fails to recognize sensory-motor issues [1], as we quote 833 the following caveat when choosing a module from the manual: "Note that the ADOS-2 was 834 developed for and standardized using populations of children and adults without significant 835 sensory and motor impairments. Standardized use of any ADOS-2 module presumes that the 836 individual can walk independently and is free of visual or hearing impairments that could 837 potentially interfere with use of the materials or participation in specific tasks" (emphasis 838 added) Catherine Lord, Rutter, DiLavore, Risi, & Western Psychological Services Firm.))" 839 Interestingly, despite this caveat for the use of the ADOS test, stated in their manual, to 840 the best of our knowledge, the makers of the ADOS test have never reported scientific studies 841 of individuals with autism where it is objectively established that individuals in the spectrum 842 of autism have no significant sensory and motor impairments. Yet, invariably, when we test 843 the children in basic scientific research labs, using high grade instruments, we do find visual, 844 hearing and touch impairments that would surely interfere with the use of the materials in 845 this test. These highly quantifiable problems with their somatic and sensory motor systems 846 are the tip of the iceberg, as deeper problems are present with their enteric nervous systems 847 (the gut) and microbiome [74; 75; 76; 77; 78] . Many suffer from pain and temperature 848 dysregulation as their overall sense of touch, vestibular issues with balance and multi-sensory 849 integration overwhelms them in ways that we can now precisely quantify in personalized 850 manner. Perhaps the new NIH-RDoC sensory-motor criteria will help WPS redefine ADOS 851 for research and encourage the use of new objective criteria grounded on biophysical metrics 852 assessing the nervous systems' functions.
853
There is by now mounting evidence that somatic-sensory-motor issues do exist across 854 the many phenotypes that go on to receive this diagnosis today under the DSM-5 broader 855 criteria. The DSM-5 allows Attention Deficit Hyperactivity Disorder (ADHD) and sensory 856 issues in the criteria for Autism. As such, Autism is no longer a narrowly, well-defined 857 disorder (perhaps it never was) despite insistence on defining it by clinical criteria that does 858 not reflect the underlying physiological conditions that these individuals possess from birth 859 onward. A new emergent field aimed at the uncovering of multiple digital biomarkers to 860 characterize and automatically stratify various aspects of behavior for research purposes, may 861 be the answer to the start of a new era in Autism scientific research aimed at a physiological 862 characterization for medical use. In our present study, it was evident that whether using 863 absolute scores, or derivative, age-dependent data accounting for longitudinal dynamic 864 changes from visit to visit, the RRB reflecting sensory motor issues, picked up best the 865 switching of the clinician. If we were to combine this structured social test with wearable 866 biosensors, we could automatically stratify Autism spectrum disorders and provide objective 867 criteria of use to the community doing basic scientific work (e.g. geneticists, 868 electrophysiologists, neuroimaging, etc.) and to the physicians treating the medical issues.
869
Some collaborative work along those lines has been done between clinicians and researchers, 870 but more research is needed to fully validate and replicate the use of digital ADOS within the 871 smart-mobile and personalized health concepts. 
Conclusions
873
We invite the readership to consider that science in Autism needs to retake the path of 874 independence and reclaim its agency to be able to conduct proper scientific research. This 875 can be done by building an inter-disciplinary consortium of scientists from diverse disciplines 876 with the skill set to derive proper metrics and true standardized methods for personalized 877 medicine. The misinformation in some cases, or lack of information in other instances, that 878 the scientific community has been subject to can easily stop by taking advantage of open 879 access data sets and teaming up with experts in the more exact sciences. More generally, 880 23 of 28 across all disciplines, we need to empirically verify inherent assumptions and understand in 881 the first place what those assumptions mean in the models that we use. Peer review within an 882 insular community will not work in favor of scientific progress. Autism is much too important 883 to ignore these recommendations. It is the future of millions of children that we scientists 884 have in our hands. Should we disrupt this lack of rigor and transform Autism science by 885 informing it with objective means? 886
